IMPACt-LBP

July 19, 2023: IMPACt-LBP Study Team Will Share Early Lessons in This Friday’s PCT Grand Rounds

Posted on by Damon Seils
Headshots of Dr. Christine Goertz and Dr. Adam Goode
From left: Dr. Christine Goertz and Dr. Adam Goode of the IMPACt-LBP NIH Collaboratory Trial

In this Friday’s PCT Grand Rounds, Dr. Christine Goertz and Dr. Adam Goode of Duke University will present “Implementing New Care Pathways for Low Back Pain in Academic Healthcare Systems: Early Lessons From IMPACt-LBP.”

The Grand Rounds session will be held on Friday, July 21, 2023, at 1:00 pm eastern.

IMPACt-LBP, an NIH Pragmatic Trials Collaboratory Trials, is a cluster randomized trial of a multidisciplinary collaborative team approach for low back pain vs usual care. The study will determine whether receiving first-line care from “primary spine practitioners” improves physical function, decreases pain and opioid prescriptions, improves patient satisfaction, and decreases costs and utilization of healthcare services.

Dr. Goertz is a professor in musculoskeletal research and the vice chair for implementation of spine health innovations in the Department of Orthopaedic Surgery, and Dr. Goode is an associate professor of orthopaedic surgery—both at Duke University.

Join the online meeting.

Grand Rounds July 21, 2023: Implementing New Care Pathways for Low Back Pain in Academic Healthcare Systems: Early Lessons From IMPACt-LBP (Christine Goertz, DC, PhD; Adam Goode, DPT, PhD)

Speakers:

Christine Goertz, DC, PhD
Professor in Musculoskeletal Research
Vice Chair for Implementation of Spine Health Innovations
Department of Orthopaedic Surgery
Duke University

Adam Goode, DPT, PhD
Associate Professor in Orthopaedic Surgery
Vice Chair of Clinical Research and Epidemiology
Department of Orthopaedic Surgery
Duke University

Topic: Implementing New Care Pathways for Low Back Pain in Academic Healthcare Systems: Early Lessons From IMPACt-LBP

Date: Friday, July 21, 2023, 1:00-2:00 p.m. ET

To join the online meeting:

Click the Zoom Meeting link below:

https://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09

Meeting ID: 961 5365 9804
Passcode: 12345

One tap mobile

+16468769923,,96153659804#,,,,*12345# US (New York)
+16469313860,,96153659804#,,,,*12345# US
Find your local number: https://duke.zoom.us/u/abvw6X2hYV

Audio Dial in Options

US:  1-646-876-9923
International: https://duke.zoom.us/u/abvw6X2hYV

Meeting ID: 961 5365 9804
Passcode: 12345

June 14, 2023: IMPACt-LBP and INSPIRE Have Updated Study Snapshots, Ethics and Regulatory Documentation

Posted on by Damon Seils

Updated study snapshots and ethics and regulatory documentation are now available for the IMPACt-LBP and INSPIRE trials, both NIH Pragmatic Trials Collaboratory Trials.

Logo for the IMPACt-LBP NIH Collaboratory TrialIMPACt-LBP transitioned from the planning phase to the implementation phase in August. As part of the transition, the study team reviewed and updated the minutes of their initial consultation with the Ethics and Regulatory Core. The study is a cluster randomized trial evaluating the effect of first-contact patient referral to physical therapists and doctors of chiropractic for the treatment of low back pain. IMPACt-LBP is supported within the NIH Collaboratory under an award from the National Center for Complementary and Integrative Health.

Logo for the INSPIRE NIH Collaboratory TrialINSPIRE joined the NIH Collaboratory at the beginning of its implementation phase. The study team held its initial consultation with the Ethics Regulatory Core to review their approach their approach to consent, data privacy, and the applicability of recent FDA guidance regarding clinical decision support software functions. INSPIRE consists of 2 cluster randomized trials that are using personalized clinical decision support to improve judicious antibiotic prescribing for non–critically ill patients hospitalized with abdominal infections or skin and soft tissue infections. The project is supported within the NIH Collaboratory under an award from the National Institute of Allergy and Infectious Diseases.

March 15, 2023: IMPACt-LBP Enrolls First Patient in Study of Collaborative Care for Low Back Pain

Posted on by Damon Seils

IMPACt-LBP, an NIH Pragmatic Trials Collaboratory Trial, enrolled its first study participant this week. Congratulations to the IMPACt-LBP study team for reaching this important project milestone!

IMPACt-LBP investigators
Dr. Christine Goertz, Dr. Adam Goode, Dr. Jon Lurie, and Dr. Rishi Chakraborty

Co-led by investigators at Duke University and Dartmouth University, IMPACt-LBP is a cluster randomized trial of a multidisciplinary collaborative team approach for low back pain versus usual care. In the intervention arm, patients with a primary complaint of low back pain are referred to physical therapists and chiropractic doctors as first-line providers. The study will determine whether receiving first-line care from these “primary spine practitioners” improves physical function, decreases pain and opioid prescriptions, improves patient satisfaction, and decreases costs and utilization of healthcare services.

Logo for the IMPACt-LBP Demonstration Project

Learn more about IMPACt-LBP in this interview with investigators Christine Goertz, Adam Goode, and Rishi Chakraborty. The study was awarded continuation to the UH3 implementation phase last summer.

IMPACt-LBP is supported within the NIH Pragmatic Trials Collaboratory by the National Center for Complementary and Integrative Health, with additional support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Child Health and Human Development.

August 22, 2022: IMPACt-LBP Awarded Continuation to Implementation Phase

Posted on by Damon Seils

IMPACt-LBP investigatorsThe NIH Pragmatic Trials Collaboratory is pleased to announce that the IMPACt-LBP NIH Collaboratory Trial received approval this month to transition from the planning phase to the implementation phase. This pragmatic clinical trial embedded in healthcare systems is studying implementation of guideline-based care for low back pain, a leading cause of ambulatory care visits in the United States.

Congratulations to the IMPACt-LBP investigators and their study teams for reaching this important milestone!

IMPACt-LBP will evaluate implementation of the American College of Physicians guideline for low back pain, which involves multidisciplinary collaborative care that includes doctors of chiropractic and physical therapists. The study will measure the effects of first-contact patient referral to these clinicians on physical function, pain, opioid prescriptions, and other patient-level outcomes.

Logo for the IMPACt-LBP NIH Collaboratory TrialThe study is administered by the National Center for Complementary and Integrative Health with additional support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Child Health and Human Development. The project is led by Drs. Christine Goertz, Adam Goode, and Hrishikesh Chakraborty of Duke University and Dr. Jon Lurie of Dartmouth Hitchcock Medical Center.

Learn more about IMPACt-LBP.

July 26, 2022: Three NIH Collaboratory Trials Share Progress on Planning, Implementation, and Completion

Posted on by Damon Seils

At this year’s annual meeting of the NIH Pragmatic Trials Collaboratory Steering Committee, we interviewed investigators from 3 NIH Collaboratory Trials in different phases of the trial life cycle. IMPACt-LBP launched last fall and is completing its 1-year planning phase. ACP PEACE is nearing the end of its implementation phase. SPOT ended last year and published its main outcomes in February.

Learn more about these innovative NIH Collaboratory Trials in the brief video updates below.

Logo for the IMPACt-LBP NIH Collaboratory TrialIMPACt-LBP, currently in the 1-year planning phase, will evaluate implementation of the American College of Physicians guideline for low back pain, which involves multidisciplinary collaborative care that includes doctors of chiropractic and physical therapists. The study will measure the effects of first-contact patient referral to these clinicians on physical function, pain, opioid prescriptions, and other patient-level outcomes. The study is administered by the National Center for Complementary and Integrative Health with additional support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Child Health and Human Development. The project is led by Drs. Christine Goertz, Adam Goode, and Hrishikesh Chakraborty of Duke University and Dr. Jon Lurie of Dartmouth Hitchcock Medical Center. Learn more about IMPACt-LBP.

Logo for the ACP PEACE NIH Collaboratory TrialACP PEACE, currently in the implementation phase, is testing an advance care planning program that combines clinician communication skills training and patient video decision aids. ACP PEACE is focused on patients with advanced cancer and their clinicians in oncology settings. The study is administered by the National Institute on Aging and is led by Drs. Angelo Volandes and James Tulsky of Harvard Medical School. Learn more about ACP PEACE.

SPOT NIH Collaboratory Trial logoSPOT, a recently completed pragmatic trial that published its main outcomes earlier this year, compared 2 low-intensity outreach programs—care management and dialectical behavior therapy skills training—to usual care in adults at risk of self-harm or suicidal behavior. The study was administered by National Institute of Mental Health and was led by Dr. Greg Simon of the Kaiser Permanente Washington Health Research Institute. Learn more about SPOT.

 

January 18, 2022: Documentation Available From Ethics and Regulatory Consultation With IMPACt-LBP NIH Collaboratory Trial

Posted on by Damon Seils

NIH Pragmatic Trials Collaboratory logo

Meeting minutes and supplementary materials summarizing a recent discussion of ethics and regulatory issues associated with the new IMPACt-LBP NIH Collaboratory Trial are now available. The consultation took place by video conference and included representation from the study’s principal investigators and project manager, members of the NIH Collaboratory’s Ethics and Regulatory Core, NIH staff, and NIH Collaboratory Coordinating Center personnel.

IMPACt-LBP is a 2-arm cluster randomized trial that will evaluate the effect of first-contact patient referral to physical therapists and doctors of chiropractic for patients with low back pain. The study aims to determine if initial contact with these clinicians will improve physical function and decrease pain, among other outcomes, in patients with a primary complaint of low back pain, when compared with usual medical care. Read more about IMPACt-LBP.

Ethics and regulatory documentation for all of the NIH Collaboratory Trials is available on our Data and Resource Sharing page.

October 21, 2021: NIH Collaboratory Launches IMPACt-LBP NIH Collaboratory Trial

Posted on by Karen Staman

IMPACt-LBP investigatorsThe NIH Collaboratory is excited to announce the addition of a new large-scale pragmatic clinical trial to its portfolio: Implementation of the American College of Physicians Guideline for Low Back Pain (IMPACt‑LBP). Co-led by investigators at the Duke Clinical Research Institute, IMPACt-LBP is a pragmatic, multisite, 2-arm cluster randomized trial that will evaluate the effect of a multidisciplinary collaborative team approach for low back pain (LBP) versus usual care. In the intervention arm, patients with a primary complaint of LBP will be referred to physical therapists and chiropractic doctors—or primary spine practitioners (PSPs)—as first-line providers.

This study aims to determine if initial contact with PSP clinicians will improve physical function, decrease pain, decrease opioid prescriptions, improve patient satisfaction, and decrease costs and utilization of health care services in patients with a primary complaint of LBP, when compared with usual medical care.

NIH Collaboratory Trials are multicenter, pragmatic trials that are embedded in healthcare delivery systems to gather real-world evidence and answer clinical questions of major public health importance. In its first 10 years, the NIH Collaboratory successfully engaged with 21 complex NIH Collaboratory Trials. IMPACt-LBP will join 6 other NIH Collaboratory Trials that focus on pain as part of a broader effort to reduce opioid prescribing and inform policy.

The results from this study will directly inform implementation and policy efforts to improve the quality of pain management for patients suffering from LBP while simultaneously reducing opioid prescriptions, health care costs and utilization of services.

The study is supported within the NIH Collaboratory by the National Center for Complementary and Integrative Health, with additional support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Child Health and Human Development.